Compounds > 5-(n-dodecanoyl)aminofluorescein
Page last updated: 2024-09-04

5-(n-dodecanoyl)aminofluorescein and Multiple Myeloma

5-(n-dodecanoyl)aminofluorescein has been researched along with Multiple Myeloma in 1 studies

*Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cahu, J; Sola, B1

Other Studies

1 other study(ies) available for 5-(n-dodecanoyl)aminofluorescein and Multiple Myeloma

ArticleYear
A sensitive method to quantify senescent cancer cells.
    Journal of visualized experiments : JoVE, 2013, Aug-02, Issue:78

    Topics: Antibiotics, Antineoplastic; beta-Galactosidase; Cellular Senescence; Doxorubicin; Flow Cytometry; Fluoresceins; Galactosides; Humans; Microbial Sensitivity Tests; Multiple Myeloma

2013